JSP Pharmaceutical Manufacturing Thailand Public : Notification of the Resolutions of the Extraordinary General Meeting of Shareholders No. 1/2022
August 16, 2022 at 06:34 am EDT
Share
(
)
(
)
JSP PHARMACEUTICAL MANUFACTURING (THAILAND) PUBLIC COMPANY LIMITED
No. JPCS-22/015
16 August 2022
Re:
Notification of the Resolutions of the Extraordinary General Meeting of Shareholders No. 1/2022
Attn:
Director and Manager, the Stock Exchange of Thailand
Since the Extraordinary General Meeting of Shareholders No. 1/2022 of JSP Pharmaceutical Manufacturing (Thailand) Public Company Limited ("Company") was held on Tuesday, 16 August 2022 at
1.30 p.m. through electronics media, the Company would like to inform the resolutions of the Extraordinary General Meeting of Shareholders No. 1/2022 as follows:
1. Resolved to approve the change of objectives of utilisation of the proceeds received from the Initial
Public Offering ("IPO"). This agenda was approved by a vote of not less than three-fourths of the total number of votes of the shareholders attending the meeting and entitled to vote, without objection votes by 10% onwards of the total number of votes of the shareholders attending the meeting and entitled to vote, with the following voting details:
Represented as a percentage of the total
number of votes of shareholders attending
Number of Votes
the meeting and entitled to vote
Approved
310,343,000
93.9457
Disapproved
20,000,000
6.0543
Abstained
1
included as base for voting calculation
Invalid Ballot(s)
0
Total Votes of the Meeting
330,343,001
100.0000
2. Resolved to approve the issuance of the warrants to purchase the newly issued ordinary shares of the Company No. 1 (JP-W1) in the amount of not exceeding 227,500,000 units for allotting to the existing shareholders in proportion of their respective shareholding (Right Offering), where allotment ratio of 2 existing ordinary shares per 1unit of Warrant to purchase the Company's ordinary shares
No. 1. This agenda was approved by the majority vote of shareholders attending the meeting and entitled to vote, with the following voting results:
(
)
(
)
JSP PHARMACEUTICAL MANUFACTURING (THAILAND) PUBLIC COMPANY LIMITED
Represented as a percentage of the total
number of votes of shareholders attending
Number of Votes
the meeting and entitled to vote
Approved
310,343,000
93.9457
Disapproved
20,000,001
6.0543
Abstained
0
included as base for voting calculation
Invalid Ballot(s)
0
Total Votes of the Meeting
330,343,001
100.0000
3. Resolved to approve the increase of the Company's registered capital amounting to Baht 113,750,000, which to be the new registered capital of Baht 341,250,000, by issuing newly ordinary shares of 227,500,000 shares with a par value of Baht 0.50 per share and the amendment to the Company's Memorandum of Associations, Clause 4. to be in line with the Company's capital increase.
This agenda was approved by a vote of not less than three-fourths of the total number of votes of the shareholders attending the meeting and entitled to vote, with the following voting results:
Represented as a percentage of the total
number of votes of shareholders attending
Number of Votes
the meeting and entitled to vote
Approved
310,343,000
93.9457
Disapproved
20,000,000
6.0543
Abstained
1
included as base for voting calculation
Invalid Ballot(s)
0
Total Votes of the Meeting
330,343,001
100.0000
4. Resolved to approve the allotment of the capital increase ordinary shares for supporting the exercise of rights of the Warrant to purchase the Company's ordinary shares No. 1 (JP-W1) in the amount of not exceeding 227,500,000 shares for allotting to the existing shareholders in proportion of their respective shareholding (Right Offering), where allotment ratio of 2 existing ordinary shares per 1unit of Warrant to purchase the Company's ordinary shares No. 1. This agenda was approved by the majority vote of shareholders attending the meeting and entitled to vote, with the following voting results:
(
)
(
)
JSP PHARMACEUTICAL MANUFACTURING (THAILAND) PUBLIC COMPANY LIMITED
Represented as a percentage of the total
number of votes of shareholders attending
Number of Votes
the meeting and entitled to vote
Approved
310,343,000
93.9457
Disapproved
20,000,001
6.0543
Abstained
0
included as base for voting calculation
Invalid Ballot(s)
0
Total Votes of the Meeting
330,343,001
100.0000
Please be informed accordingly.
Sincerely yours,
JSP Pharmaceutical Manufacturing (Thailand) PCL.
Investor Relations
Ms. Jirada Daengprasert
Tel. 064 479 1691
Company Secretary
Emailir@jsppharma.com
On behalf of the Board of Directors
Attachments
Original Link
Original Document
Permalink
Disclaimer
JSP Pharmaceutical Manufacturing Thailand pcl published this content on 16 August 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 16 August 2022 10:33:04 UTC.
JSP Pharmaceutical Manufacturing (Thailand) PCL is a Thailand-based company, which manufactures and distributes conventional medicines. The Company manufactures and distributes products under customerâs brand name (OEM), as well as under the Companyâs brand name. The Company develops, manufactures and sells conventional and traditional medicines, herbal products and dietary supplements, providing a range of services covering the manufacturer and the seller of the products under both customersâ trademark (OEM) and the seller of the products under the Companyâs trademark (Own Brand). The Company develops herbal products, dietary supplements with natural extracts and plant-based protein under brand name Supap Osot, and dietary supplements such as using new raw materials or having new production process for both beauty and health under brand name EVITON. The Companyâs subsidiary, Caresutic Co., Ltd., is engaged in manufacturing and distribution of dietary supplements and cosmetic products.